Jolanta J. Cholon

635 total citations · 1 hit paper
6 papers, 561 citations indexed

About

Jolanta J. Cholon is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Jolanta J. Cholon has authored 6 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Epidemiology. Recurrent topics in Jolanta J. Cholon's work include Virus-based gene therapy research (3 papers), RNA Interference and Gene Delivery (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Jolanta J. Cholon is often cited by papers focused on Virus-based gene therapy research (3 papers), RNA Interference and Gene Delivery (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Jolanta J. Cholon collaborates with scholars based in United States. Jolanta J. Cholon's co-authors include Joseph J. Tumilowicz, Warren W. Nichols, Arthur E. Greene, George P. Studzinski and John F. Gierthy and has published in prestigious journals such as Science, Experimental Biology and Medicine and In Vitro Cellular & Developmental Biology - Plant.

In The Last Decade

Jolanta J. Cholon

6 papers receiving 509 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition of a continuous human cell line derived from neuroblastoma.

1970 436 citations Joseph J. Tumilowicz, Warren W. Nichols et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jolanta J. Cholon United States	5	341	205	88	84	68	6	561
Annika Jalava Finland	12	367 1.1×	51 0.2×	115 1.3×	46 0.5×	53 0.8×	13	582
Joh-E Ikeda Japan	14	350 1.0×	113 0.6×	27 0.3×	149 1.8×	26 0.4×	18	556
Ferenc Garzuly Hungary	13	393 1.2×	194 0.9×	49 0.6×	39 0.5×	26 0.4×	37	918
Gayle A. Shinder Canada	9	383 1.1×	217 1.1×	27 0.3×	75 0.9×	30 0.4×	14	716
Maureen Mee United Kingdom	11	412 1.2×	115 0.6×	108 1.2×	73 0.9×	81 1.2×	14	678
C. E. Lumsden United Kingdom	14	253 0.7×	111 0.5×	41 0.5×	25 0.3×	13 0.2×	21	821
Hannes Wickert Germany	15	339 1.0×	89 0.4×	94 1.1×	39 0.5×	25 0.4×	23	856
Keith Edgemon United States	9	607 1.8×	158 0.8×	211 2.4×	242 2.9×	65 1.0×	9	1.0k
Evelyn C. Ilg Switzerland	12	708 2.1×	62 0.3×	56 0.6×	44 0.5×	176 2.6×	21	837
Francisco Meirelles Bastos de Oliveira Brazil	15	646 1.9×	107 0.5×	126 1.4×	95 1.1×	87 1.3×	25	906

Countries citing papers authored by Jolanta J. Cholon

Since Specialization

Citations

This map shows the geographic impact of Jolanta J. Cholon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta J. Cholon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta J. Cholon more than expected).

Fields of papers citing papers by Jolanta J. Cholon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta J. Cholon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta J. Cholon. The network helps show where Jolanta J. Cholon may publish in the future.

Co-authorship network of co-authors of Jolanta J. Cholon

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta J. Cholon. A scholar is included among the top collaborators of Jolanta J. Cholon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta J. Cholon. Jolanta J. Cholon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Cholon, Jolanta J., et al.. (1979). Inhibition of cellular transition from G1-resting to G1-prereplicative phase by aminonucleoside or puromycin. In Vitro Cellular & Developmental Biology - Plant. 15(9). 736–742. 2 indexed citations

2.

Cholon, Jolanta J. & George P. Studzinski. (1974). Metabolic Differences between Normal and Neoplastic Cells: Effects of Aminonucleoside on Cytoplasmic Messenger RNA. Science. 184(4133). 160–161. 13 indexed citations

3.

Cholon, Jolanta J. & George P. Studzinski. (1974). Effect of aminonucleoside on serum stimulation of nonhistone nuclear protein and DNA synthesis in normal and SV40-transformed human fibroblats.. PubMed. 34(3). 588–93. 20 indexed citations

4.

Studzinski, George P., John F. Gierthy, & Jolanta J. Cholon. (1973). An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures. In Vitro Cellular & Developmental Biology - Plant. 8(6). 466–472. 73 indexed citations

5.

Tumilowicz, Joseph J. & Jolanta J. Cholon. (1971). Intracisternal Type A Particles and Properties of a Continuous Cell Line Originating from a Gerbil Fibroma. Experimental Biology and Medicine. 136(4). 1107–1110. 17 indexed citations

6.

Tumilowicz, Joseph J., Warren W. Nichols, Jolanta J. Cholon, & Arthur E. Greene. (1970). Definition of a continuous human cell line derived from neuroblastoma.. PubMed. 30(8). 2110–8. 436 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact